UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas

PloS one, 2013-11, Vol.8 (11), p.e81167-e81167

2013

Volltextzugriff (PDF)

Transperitoneal Enucleation of a Kidney Transplant Allograft Renal Cell Carcinoma

Experimental and clinical transplantation, 2018-10, Vol.16 (5), p.614-616

2018

Volltextzugriff (PDF)

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis

The Journal of pathology, 2001-06, Vol.194 (2), p.152-157

2001

Volltextzugriff (PDF)

Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma

The American journal of surgical pathology, 2003-01, Vol.27 (1), p.11-15

2003

Volltextzugriff (PDF)

ANCA renal risk score predicts outcome in the Manchester cohort

Kidney international, 2019-07, Vol.96 (1), p.246-247

2019

Volltextzugriff (PDF)

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

Clinical cancer research, 2017-08, Vol.23 (16), p.4761-4768

2017

Volltextzugriff (PDF)

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Clinical cancer research, 2013-09, Vol.19 (17), p.4879-4888

2013

Volltextzugriff (PDF)

Hypoxia-associated gene signatures are not prognostic in high-risk localised prostate cancers undergoing androgen deprivation therapy with radiotherapy

International journal of radiation oncology, biology, physics, 2024-10

2024

Volltextzugriff (PDF)

112. VALIDATION OF RENAL ANCA SCORE

Rheumatology (Oxford, England), 2019-03, Vol.58 (Supplement_2)

2019

Volltextzugriff (PDF)

A man who brought the war home with him

The Lancet (British edition), 2008-11, Vol.372 (9653), p.1926-1926

2008

Volltextzugriff (PDF)

Sertoliform cystadenoma of the rete testis

Pathology international, 2006-09, Vol.56 (9), p.568-569

2006

Volltextzugriff (PDF)

Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy

BMC nephrology, 2007-05, Vol.8 (1), p.7-7, Article 7

2007

Volltextzugriff (PDF)

MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer

International journal of radiation oncology, biology, physics, 2019-07, Vol.104 (4), p.809-818

2019

Volltextzugriff (PDF)

A hypoxia transcriptomic signature to predict benefit from hypoxia-modifying treatment for muscle-invasive bladder cancer patients

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.301-301

2017

Volltextzugriff (PDF)

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue

Scientific reports, 2020-10, Vol.10 (1), p.17258-17258, Article 17258

2020

Volltextzugriff (PDF)

Predicting Invasion in Mammographically Detected Microcalcification

Clinical radiology, 2001-10, Vol.56 (10), p.828-832

2001

Volltextzugriff (PDF)

The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)

British journal of cancer, 2017-02, Vol.116 (5), p.649-657

2017

Volltextzugriff (PDF)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial

Radiotherapy and oncology, 2013-07, Vol.108 (1), p.40-47

2013

Volltextzugriff (PDF)

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

Molecular medicine reports, 2022-08, Vol.26 (2), Article 261

2022

Volltextzugriff (PDF)

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

EBioMedicine, 2024-03, Vol.101, p.105032-105032, Article 105032

2024

Volltextzugriff (PDF)

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialResearch in context

EBioMedicine, 2024-03, Vol.101, p.105032

2024

Volltextzugriff (PDF)

Recurrent tubulointerstitial nephritis and uveitis syndrome in a renal transplant recipient

Nephrology, dialysis, transplantation, 2011-09, Vol.26 (9), p.3060-3062

2011

Volltextzugriff (PDF)

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder

Journal of biophotonics, 2013-01, Vol.6 (1), p.73-87

2013

Volltextzugriff (PDF)

Investigation into the possible cause of subjective decreased Sensory perception in the nipple-areola complex of women with macromastia

Plastic and reconstructive surgery (1963), 2004-05, Vol.113 (6), p.1598-1606

2004

Volltextzugriff (PDF)

Abstract LB-450: Necrosis predicts benefit from hypoxia-modifying therapy in urothelial cell carcinoma of the bladder

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.LB-450-LB-450

2012

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)
Berichte
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Humans
(20)
Female
(11)
Male
(10)
Middle Aged
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Oncology
(8)
Aged
(7)
Bladder Cancer
(7)
Urinary Bladder Neoplasms - Pathology
(7)
Adult
(6)
Treatment Outcome
(6)
Radiotherapy
(5)
Tumors
(5)
Aged, 80 And Over
(4)
Cancer
(4)
Hypoxia
(4)
Prospective Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas

Transperitoneal Enucleation of a Kidney Transplant Allograft Renal Cell Carcinoma

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis

Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma

ANCA renal risk score predicts outcome in the Manchester cohort

A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

Hypoxia-associated gene signatures are not prognostic in high-risk localised prostate cancers undergoing androgen deprivation therapy with radiotherapy

112. VALIDATION OF RENAL ANCA SCORE

A man who brought the war home with him

Sertoliform cystadenoma of the rete testis

Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy

MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer

A hypoxia transcriptomic signature to predict benefit from hypoxia-modifying treatment for muscle-invasive bladder cancer patients

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue

Predicting Invasion in Mammographically Detected Microcalcification

The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trialResearch in context

Recurrent tubulointerstitial nephritis and uveitis syndrome in a renal transplant recipient

FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder

Investigation into the possible cause of subjective decreased Sensory perception in the nipple-areola complex of women with macromastia

Abstract LB-450: Necrosis predicts benefit from hypoxia-modifying therapy in urothelial cell carcinoma of the bladder

Suchergebnisse filtern